Top Companies in Surgical Sutures Market

The global surgical sutures market is projected to reach USD 5.5  billion by 2028 from USD 4.0 billion in 2023, at a CAGR of 6.4% during the forecast period. Factors such as The rise in age-related health issues, trauma, and chronic diseases have led to a higher need for surgical interventions and medical devices used in the healing process, such as surgical sutures. Advanced technological approaches in suture techniques are shaping the market, enhancing cost efficiency, and reducing the risk of surgical infections for patients. However, increasing preference for minimally invasive surgeries and the presence of alternative wound care management products are some of the key factors restraining the growth of the surgical sutures market.

Prominent players in the surgical sutures market include Ethicon, Inc. (a subsidiary of Johnson & Johnson) (US), Medtronic Plc (Ireland), B. Braun SE (Germany), Advanced Medical Solutions Group Plc (UK), Internacional Farmacéutica S.A. de C.V. (Mexico), Peters Surgical (France), Corza Medical (US), Boston Scientific Corporation (US), DemeTECH Corporation (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Smith & Nephew Plc (UK), CONMED Corporation (US), Mellon Medical B.V. (Netherlands), Unisur Lifecare Pvt. Ltd. (India), Assut Europe (UK), Katsan Katgüt Sanayi ve Tic. A.S. (Turkey), Sutumed Corp. (US), Aqmen Medtech Pvt. Ltd. (India), Futura Surgicare Pvt. Ltd. (India), Anchora Medical Ltd. (Israel), Lotus Surgicals (India), Biosintex (Romania), and Meril Life Sciences Pvt. Ltd. (India). These companies adopted strategies such as product launches, partnerships, collaborations, and acquisitions to strengthen their market presence in the surgical sutures market.

To know about the assumptions considered for the study download the pdf brochure

Ethicon stands as a prominent participant in the worldwide surgical suture market. The company boasts a diverse portfolio of surgical suture products encompassing absorbable and non-absorbable sutures, antibacterial coated sutures, tissue control devices, and automated suturing devices. Employing a combination of organic and inorganic growth strategies, including product launches, collaborations, and acquisitions, Ethicon diligently upholds its dominant position in the market. Renowned for its innovation-driven approach, the company places a strong emphasis on research and development to create cutting-edge, technologically advanced products. In 2022, the company launched DYNACORD sutures, which can be used for soft tissue approximation in rotator cuff repairs. The company’s key strengths are based on its strong geographic presence, technologically diverse product portfolio, and wide distribution network across major markets (such as the US, the UK, Switzerland, and Sweden, among others).

Medtronic held the second position in the global surgical sutures market, with a share of 15.9% in 2022. The company’s leading position can be attributed to its vast portfolio of absorbable sutures, non-absorbable sutures, barbed sutures, and automated suturing devices. The company focuses on inorganic growth strategies to achieve growth. In February 2020, the company acquired Digital Surgery (UK) to accelerate its digital surgery portfolio.

The company also strategically invests in R&D to strengthen its position in the market. This rise in R&D spending indicates the company's increased focus on innovation and diversification in emerging markets. Its strong investments in developing innovative products have helped it become a reputed player in the surgical sutures market.

Related Reports:

Surgical Sutures Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread (Natural, Polypropylene, Stainless Steel, Antimicrobial)), Application (Cardiac, Gynae, Cosmetic, Ortho), End User & Region - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]